Industry / India
Diabetes Sector Targeted By Leading Players
May 2008 | Industry NewsIt is BMI's view that the diabetes epidemic in India represents a significant opportunity for drugmakers. The debilitating condition accounts for a large portion of the country's burden of disease and the problem is growing. Appreciating this situation, two of leading multinational drugmakers have announced plans for launching their innovative products onto the
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
